Area of research
Oncology · Epidemiology
Research interest
Research interests include Nonmelanoma Skin Cancer Studies, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, and Cutaneous Melanoma Detection and Management.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma